Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 137.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 150.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.82m
  • Volume: 70,319
  • Market Cap: £116.63m
  • RiskGrade: 196
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
73.62% above the market average73.62% above the market average73.62% above the market average73.62% above the market average73.62% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
17.23% above the market average17.23% above the market average17.23% above the market average17.23% above the market average17.23% above the market average
41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average
Price Book Ratio
57.31% below the market average57.31% below the market average57.31% below the market average57.31% below the market average57.31% below the market average
18.75% below the sector average18.75% below the sector average18.75% below the sector average18.75% below the sector average18.75% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
83.28% above the market average83.28% above the market average83.28% above the market average83.28% above the market average83.28% above the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Price Chg 3m
17.85% above the market average17.85% above the market average17.85% above the market average17.85% above the market average17.85% above the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
97.04% above the market average97.04% above the market average97.04% above the market average97.04% above the market average97.04% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Momentum 20
68.51% above the market average68.51% above the market average68.51% above the market average68.51% above the market average68.51% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
52.35% below the market average52.35% below the market average52.35% below the market average52.35% below the market average52.35% below the market average
3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
67.93% below the market average67.93% below the market average67.93% below the market average67.93% below the market average67.93% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
12.78% below the market average12.78% below the market average12.78% below the market average12.78% below the market average12.78% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Operating Profit Loss
59.97% below the market average59.97% below the market average59.97% below the market average59.97% below the market average59.97% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
3.31% above the market average3.31% above the market average3.31% above the market average3.31% above the market average3.31% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Cash
14.79% above the market average14.79% above the market average14.79% above the market average14.79% above the market average14.79% above the market average
39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
20.30% above the market average20.30% above the market average20.30% above the market average20.30% above the market average20.30% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Buys 1y
69.43% below the market average69.43% below the market average69.43% below the market average69.43% below the market average69.43% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 137.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 150.00
52 Week Low 108.00
Volume 70,319
Shares Issued 84.82m
Market Cap £116.63m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.9% below the market average32.9% below the market average32.9% below the market average32.9% below the market average32.9% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average
Price Trend
35.60% above the market average35.60% above the market average35.60% above the market average35.60% above the market average35.60% above the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Income Not Available
Growth
48.10% above the market average48.10% above the market average48.10% above the market average48.10% above the market average48.10% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for 15-Aug-2025

Time Volume / Share Price
16:54 36,276 @ 137.50p
16:18 1,067 @ 139.40p
14:53 30,000 @ 139.00p
10:22 2,514 @ 139.00p
08:02 36 @ 140.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page